Direct injection of VX2 cell suspension into the liver is simple and widely used. Implantation of a fragment of VX2 tumour into the liver using a surgical technique has also been developed in the last decade. In this study, we compared these two methods in order to nd a better modality for establishing VX2 liver mass. Forty rabbits, each weighing 2.8-3.2 kg, were divided into two groups, 20 rabbits in each. In Group 1, a tumour cell suspension containing 1610 6 cells in a volume of 0.1 ml, was injected slowly into the liver parenchyma using a 27-gauge needle during laparotomy. In Group 2, a 1 mm 3 fragment of VX2 carcinoma was inoculated into the sub-capsule of the left anterior lobe of the liver. In Group 1, three rabbits showed no tumour growth and 10 rabbits showed evidence of leakage and tumour seeding outside of the liver. In Group 2, all but one rabbit showed tumour growth and none showed evidence of tumour seeding. The leakage rates were 50% and 0% for Group 1 and Group 2, respectively. Overall, the success inoculation rate was 35% for Group 1 and 95% for Group 2. In conclusion, to create the VX2 liver tumour model in rabbits, direct implantation of VX2 tumour fragment into the liver achieved better results than injecting cell suspension of VX2 tumour into the liver.
Hepatocellular carcinoma (HCC) is the common form of primary hepatic carcinoma. The incidence of this disease worldwide is estimated to be 1 000 000 new cases per year, with a male-to-female ratio of about 4:1. It has a heterogenous geographical distribution. In high-risk areas such as China, Taiwan, Japan, South Africa and the Mediterranean basin, the annual incidence of HCC is between 40-150 cases per 100 000. In lowrisk areas such as Northern Europe, USA and Canada, the incidence is less than 5 cases per 100 000. HCC causes almost one million deaths annually (London 1981 , Okuda et al. 1985 , Akriviadis et al. 1998 . It frequently affects patients with chronic liver disease and liver cirrhosis. The exact pathogenesis on how chronic liver disease and liver cirrhosis result in HCC is still unclear. One possible mechanism implicates the cirrhotic process per se through the appearance of foci of hepatocyte dysplasia within the regenerative nodules, followed by de nitive neoplastic transformation and clonal expansion as 'nodule in the nodule'. The presence of regenerative nodules in the cirrhotic liver represents the main determinant of both the pathogenesis and morphogenesis of the tumour. In addition, chronic liver disease and cirrhosis are commonly caused by hepatitis infection, and these viruses may also directly promote neoplastic transformation by a number of molecular events (Borzio et al. 1997 , Benvegnu et al. 2001 . Surgery is the best method for increasing survival time. However, resection is only possible in a small proportion of patients because of underlying advanced cirrhosis (Shiu et al. 1990 , Macintosh & Minuk 1992 . Only 10-20% of the primary liver tumours are found to be respectable (Pergolizzi et al. 1999) . The difculties posed by HCC management have prompted the development of numerous potential curative treatments such as transcatheter hepatic arterial embolization (TAE), percutaneous injection of materials that kill cancer cells, and percutaneous thermal and cryotherapy (Ebara et al. 1990 , Yamashita et al. 1993 , Cuschieri et al. 1995 , Livraghi et al. 1995 , Lin et al. 1997 , 2000 . As such, a good animal model with liver tumour is very important in the search for a good therapeutic method.
The VX2 carcinoma is an animal tumour, which is being used extensively to study different aspects of tumour behaviour and is generally accepted for the establishment of a liver tumour. The VX2 carcinoma cells, rst developed by Shope and Hurst (1933) , are derived from a virus-induced papilloma of rabbits. It is a fast-growing adenocarcinoma and has been used in several rabbit models (Rougier et al. 1990 ). In previous investigations, cell suspension of VX2 tumour has been injected via several routes including directly into the liver parenchyma (Izumi et al. 1986) , into the hepatic artery or portal vein (Burgener & Violante 1979) and into the gastrointestinal walls (Tabuchi et al. 1991 ) to achieve liver tumour (VX2) growth. Direct injection of VX2 cell suspension into the liver parenchyma is simple and widely used but leakage of tumour cells into the peritoneal cavity via the injection route is not uncommon (Berkowitz et al. 1975 , Burgener & Violante 1979 , Izumi et al. 1986 ). Instead of injecting VX2 cell suspension, some authors implanted a small piece of solid VX2 tumour into the liver of rabbits and successfully achieved a liver tumour (Phillips et al. 1991 , Ikeda et al. 1993 , Thorstensen et al. 1994 ).
However, to the best of our knowledge, no comparison between these two methods has been made in the literature. In this study, we compared the success rate of these two inoculation techniques to identify which one is better at forming VX2 liver tumour in rabbits.
Materials and methods

Preparation of VX2 cell suspension and VX2 cell mass
The VX2 carcinoma (BCRC, Bioresource Collection and Research Center, Taipei, Taiwan) is an anaplastic squamous cell carcinoma derived from a virus-induced papilloma in the wild rabbit, but appears as a carcinoma in the domestic species. Ten New Zealand white rabbits (supplied by Taichung Veterans General Hospital, Taichung, Taiwan) were given injections of 0.5 ml VX2 carcinoma suspension, each millilitre containing 5610 7 tumour cells. The suspension was injected intramuscularly using a 1 ml syringe into the left hind leg below the knee of the rabbits. The VX2 strain has been maintained by serial transfer of the tumour homogenate into the thigh muscle of the rabbits. Following implantation into the hind legs, the tumour enlarged rapidly. When the tumour grew to a size of about 5 cm in diameter, the tumour was ready for preparation of cell suspension and tumour grafting.
Immediately after sacri ce of the rabbit under anaesthesia with intravenous injection of sodium pentobarbital (30 mg=kg), the VX2 tumour was aseptically stripped from the surrounding connective tissues and minced mechanically with surgical knives and scissors in a cold (4¯C) physiological buffered saline (PBS)(Gibco, Paisley, UK). Then the cell suspension was ltered through an iron mesh with 0.08 mm 2 pores to remove macroscopic tissue fragments. The ltrate was centrifuged at 2000 rpm for 10 min under room temperature and resuspended using PBS to a concentration of 1610 7 cells=ml. Trypan blue was used to evaluate the viability of the VX2 carcinoma cells. The cell suspension was then ready for injection.
For VX2 cell mass, the tumour was excised from the hind limb of the rabbit, and the surrounding connective tissue and fat were removed from the tumour. Then, the tumour was cut into 1 mm 3 pieces in a PBS solution and was ready for implantation.
All the procedures of cell=tumour isolation were performed under hood.
Animals and implantation of VX2 cancer cells
Forty New Zealand white rabbits (supplied by Taichung Veterans General Hospital, Taichung, Taiwan), each weighing about 2.8-3.2 kg, were used for the experiment. Food and water were given ad libitum. The animal care and use procedures were in accordance with the Guide for the Care and Use of Laboratory Animals in our hospital. To implant the VX2 carcinoma cell suspension into the liver, a sub-xyphoid laparotomy, 3-5 cm in length, was performed to expose the left lobe of the liver after anaesthesia with 20% xylazine hydrochloride (4 mg=kg) and ketamine (10 mg=kg). The rabbits were divided into two groups (20 rabbits in each group). In Group 1, under conditions of a sterile laparotomy, a tumour cell suspension containing 1610 6 cells in a volume of 0.1 ml, was injected slowly into the left anterior lobe under the liver capsule, raising a visible pale wheal, using a 27-gauge needle with a 1 ml syringe (Fig 1) . The puncture site was then gently compressed, using an alcoholic cotton gauze, for 3 min to prevent bleeding and leakage of cancer cells after removal of the needle. Then the wound was closed in layers. In Group 2, under conditions of a sterile laparotomy, a 1 mm 3 fragment of VX2 carcinoma was inoculated into the sub-capsule of the left anterior lobe of the liver (Fig 2) . Before the wound was closed in layers, 0.5 ml of Shotapen (Benzathin Penicillin G 10 000 IU ‡ Procaine Penicillin G 10 000 IU ‡ Dihydrostreptomycin 200 mg=ml; Virbac Laboratories, Paris, France) was dripped into the peritoneal cavity to prevent infection. After the surgical procedure, all rabbits were observed closely to evaluate the possible postoperative pain. Four criteria were used for the evaluation: (1) hyperactivity, hypoactivity or inactivity; (2) increase in vocalization; (3) decrease or no intake of food or water; and (4) increase of teeth grinding. It was our intention to prescribe analgesics for any rabbit showing signs of one or more of these criteria, but none did, and therefore postoperative analgesics were not given. Two weeks after implantation, the animals were killed via intravenous pentobarbital. Laparotomy was then performed to check the growth of the tumour and the tumour was resected for microscopic examination. Tumour spreading over the surrounding organs and peritoneal cavity was considered to be secondary tumour caused by the leakage of the tumour cells from the injection route. Evidence of leakage or no tumour growth was considered to be a failed implantation. Tumour growth con ned to the liver was considered to be a successful implantation.
Microscopic examination
The specimens were xed in 10% formaldehyde (Mallinckrodt Baker, Inc. Deventer, Holland), sectioned in a size of about 363 cm and stained with haematoxylin and eosin (H&E) (Merck & Co., Inc., Darmstadt, Germany).
Statistical analyses
Statistical analyses were made using the Fisher's exact test. A P value less than 0.05 was considered to be statistically signi cant. Table 1 shows the result of implantation of VX2 carcinoma cells into the liver of rabbits using the two methods. The tumour sizes in these rabbits were averagely between 3-5 cm in diameter and there was no big difference of tumour size between groups and individuals. In Group 1, three rabbits showed no evidence of tumour growth. Of the 17 rabbits with tumour growth, seven rabbits had VX2 carcinoma growth con ned to the liver (Fig 3) , while 10 rabbits showed evidence of leakage and had tumour growth in the peritoneal cavity or surrounding organs (Fig 4) . One rabbit (5%) showed lung metastases. The leakage rate was 50% and the success rate was 35%. In Group 2, only one rabbit showed no evidence of tumour growth. Of the 19 rabbits with tumour growth, none showed evidence of leakage. The success rate was 95%. There was a statistical difference in success rates between these two groups with a P value of 0.0001. Microscopic ndings revealed considerable growth of the VX2 tumour with central necrosis in the liver (Fig 5) .
Results
Discussion
The VX2 carcinoma is a highly malignant anaplastic squamous cell carcinoma that develops as the result of a spontaneous transformation of a virus-induced skin papilloma in the domestic rabbit. Therefore, it has been used extensively to study different aspects of liver tumour behaviour. The VX2 tumour grows very fast. In our study, the microscopic examination showed that the VX2 tumour was growing very well 2 weeks after implantation.
Our experiment showed the leakage rate was as high as 50% (10=20) in Group 1 (injection of VX2 cell suspension into the liver). Two reasons may explain this phenomenon: one is that cells are inoculated, not only to the parenchyma, but also into blood vessels and bile ducts; the other is that tumour cells may leak from the puncture site. It is necessary therefore to make sure that the needle is not in a vessel or a bile duct by withdrawing the syringe before injection of the VX2 cells (Burgener & Violante 1979 , Izumi et al. 1986 ). In addition, compressing the puncture site with cotton gauze may reduce the leakage rate from the puncture route. However, our results were still unsatisfactory. Conversely, in Group 2 (implantation of a tumour fragment), there was no evidence of leakage. The difference of leakage rate between these two methods was very signi cant. Transplantation of a tumour fragment may imply a de ned tumour location. There is no risk of initial spread or leakage of the tumour, thus allowing for a more predictable appearance of tumour tissue (Phillips et al. 1991 , Ikeda et al. 1993 , Thorstensen et al. 1994 . Moreover, the success rate in Group 2 was higher than that in Group 1.
Our data showed that implantation of a tumour fragment into the liver directly using a surgical technique may be a more promising method than the method of injecting cell suspension. However, there are also some disadvantages of the tumour fragment method. This surgical technique is more traumatic than the use of the suspension injection method. Therefore this technique is limited to the establishment of a multiple liver tumour model. Surgical complications in the liver such as haemorrhage, bile leakage, or abscess are more likely to occur. In addition, it is very dif cult to control the same number of viable tumour cells in every tumour fragment, but this is easy to achieve using the cell suspension technique. Furthermore, failure of implantation may occur when necrotic tissue instead of viable tumour cells is implanted into the liver. To reduce the possibility of implanting nonviable tumour cells into the liver, the tumour fragment should be taken carefully from the periphery of the 'mother' tumour. The peripheral part of the tumour usually contains viable tumour cells and is in a solid consistency that is unlike the sludge-like consistency of the necrotic center of the tumour (Thorstensen et al. 1994) .
In conclusion, to create a VX2 liver tumour in rabbits, our ndings clearly indicate that the method of directly implanting a tumour fragment achieves higher success rates than the method of injecting cell suspension of VX2 tumour into the liver.
